Drissana Tran
Internal Medicine · Salem, ORNPI 1164501722
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $53 of the $53 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, BD.
Across 1 payment — averaging $53.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$53
Across 282 payments — averaging $16,854 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$4M
- AbbVie$341K
- Teva Pharmaceuticals USA, Inc.$143K
- Sage Therapeutics, LLC$93K
- Supernus Pharmaceuticals, Inc.$66K
- Biohaven Pharmaceuticals, Inc.$49K
- plus $66K from 4 others
What the payments were for
- Speaking & faculty fees$53100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 1 | $53 |
How this compares
$53 in reported general payments places this provider in the 60th percentile of 1,363 internal medicine providers in Oregon.
Other internal medicine in Salem
- Elisabeth JappaySalem$4K
- Chad PfeferBeaverton$639K
- Pranav ChandrashekarPortland$81K
- Jonathan EdmistonBend$68K
- Jessica CastlePortland$66K
- Ellen Schiaffino PurvisGresham$66K
- Steven ShawWhite City$58K
- Stephen SpurgeonPortland$42K
- Jane BabiarzPortland$30K
- Andrew HarbisonPortland$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.